Sexual problems are often expressed as secrets, and individuals are embarrassed or feel ashamed to address them. Individuals' refusal to seek help for specific sexual problems has led to the negligence of these disorders, resulting in limited treatments (
1,
2). Premature ejaculation (PE) is one of these problems and is a common sexual dysfunction in men. Even though the true prevalence rate of PE is not specified, it might affect 20 to 30% of men regardless of age and race (
3). PE affects various aspects of the patient's life, including mental and emotional health and interpersonal relationship with their spouse (
4). Despite this, PE is a part of men's sexual health that is generally disregarded, indicating an unmet medical need. This is probably due to many factors, such as the low rate of seeking medical help due to shame and physicians' confusion regarding the clinical management of this dysfunction (
5,
6). PE in men can lower self-esteem and lead to concerns regarding the impact of this problem on the quality of their interpersonal relationships. The main impact of PE on men's lives is diminished sexual confidence. Anxiety about performing well, shame regarding the current state, and depression are among the effects caused by PE in men (
7). Various treatments have been suggested for this disorder; however, their effects are not permanent or inclusive.
A few drug therapies have been suggested for PE, none of which are currently approved as effective treatments. Tricyclic antidepressants (TCAs) are effective in treating PE; however, their use is restricted because of their considerable side effects, such as anticholinergic effects, including nausea, dry mouth, blurred vision, and cardiovascular toxicity (
8,
9). Clomipramine is a primary agent used as PE treatment and has proven effective in increasing the time interval between penetration and ejaculation. Tramadol has also been tested as a potential treatment for PE. The exact mechanism is unknown, but it is assumed that tramadol might operate as an agonist, an antagonist of the HT2C5 receptor, and a modulator of serotonin and norepinephrine (noradrenaline) (
10). Considering the limited research base, it is essential to conduct more investigations to determine the safety and effectiveness of drugs for these patients. Moreover, psychotherapy is another option that can benefit patients with PE.
Psychotherapy might provide patients with PE with a mental, natural, or acquired variable and specify this disorder's interpersonal or psychological causes (
6). The physician can discover and examine deeper psychological and interpersonal factors in these methods. Psychological treatment might be effective in reducing the distress associated with PE. The evidence that supports the psychological procedures to manage PE is contradictory and lacks long-term follow-up (
8). Some have posed the question of whether PE is merely psychological.
Some researchers have found differences in nerve conduction/delay and hormonal differences in men with PE compared with men who do not experience PE. This theory states that some men suffer from excessive stimulation or sensitivity of reproductive organs, which prevents the regulation of sympathetic paths and leads to a delay in orgasm (
3,
11). Electroencephalography studies and neuroimaging have detected abnormal responses and activation of the brain to ergogenic stimulation and changes in brain structure in patients with PE. A study by Lu et al. (
12) used functional magnetic resonance imaging (fMRI) and demonstrated that patients with lifelong PE have an abnormal brain control network that facilitates the reduction of central control of early ejaculation. Ejaculation is a spinal reflex subject to acute neuromodulation. It comprises two steps. Discretion and discharge of this coordination guarantee the unstable propulsion of semen. It secretes into the urinary tract and is followed by discharge, a process in which rhythmic muscular contractions and pelvic muscles lead to the movement and discharge of semen through the urinary tract (
13-
15). Examining transcranial direct current stimulation (tDCS) can effectively treat PE since the brain is effective in these actions and reactions.
Brain stimulation includes invasive and non-invasive methods currently discussed in the field of neurological sciences (
16,
17). tDCS is a method that applies a continuing and low-intensity electrical current to the head. This type of stimulation is an invasive method to stimulate the brain, which is influential in modulating cortical arousal and the direction of human behavior and perception (
18,
19). Over the past two decades, numerous studies have demonstrated positive clinical results using this method (
20). Transcranial direct current stimulation is a weak current that causes temporary changes in the stimulation of cortical regions. Physical parameters of tDCS include current severity, stimulation site, electrode size, stimulation duration, and current polarity (anode or cathode), each of which causes different effects (
21). In this method, large electrodes are placed on the head that passes through a continuous and weak current. The effectiveness of tDCS depends on the direction of the electrical current. Anode stimulation increases the brain's activity and stimulation, and cathode stimulation reduces it (
22,
23).